| J0897 | Injection, denosumab, 1 mg | 8,460 | $20 | $160.7K |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 4,750 | $30 | $118.8K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 69,750 | $1 | $69.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 660 | $100 | $67.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 840 | $70 | $60.8K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 770 | $70 | $51.5K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 8,050 | $10 | $48.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 350 | $120 | $40.3K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 3,820 | $10 | $22.9K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 2,180 | $10 | $17.4K |